The Clinical Trials Guru's Dan Sfera on Innovation in Phase 1 Studies and Beyond
Hosted By : Andrea CharlesJuly 30, 2012
Rate this Podcast:
(Be the First!)
About this Podcast...
It’s no secret that pharma and bio are struggling to fill their pipelines. Dan Sfera from The Clinical Trials Guru, joins Andrea Charles from Pharma IQ to discuss specific challenges that arise in conducting Phase 1 studies and the additional skills that are required to overcome them, barriers to participation in early phase clinical trials and the potential challenges and opportunities of using biomarkers and when is the optimum time to start development.
Sfera also shares his insights on how NDA approval rates will be affected by regulatory changes and how increasing partnerships between pharmaceutical companies and CROs are changing the clinical development landscape.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Rate this Podcast:
(Be the First!)
Events of Interest
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Register Now -
Use of Cardiac Safety Data in Early Phase Trials to Supplement or Replace a Thorough QT Trial
June 11, 2012
Register Now -
Site Quality Management and Risk-Based Monitoring: A New Approach
December 4, 2012
Register Now -
Outlicensing – and Beyond
November 8, 2012
Register Now





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!